IONS
Price
$31.43
Change
-$0.85 (-2.63%)
Updated
Jan 17 closing price
Capitalization
4.96B
31 days until earnings call
LXEO
Price
$5.07
Change
-$0.12 (-2.31%)
Updated
Jan 17 closing price
Capitalization
167.7M
57 days until earnings call
Ad is loading...

IONS vs LXEO

Header iconIONS vs LXEO Comparison
Open Charts IONS vs LXEOBanner chart's image
Ionis Pharmaceuticals
Price$31.43
Change-$0.85 (-2.63%)
Volume$1.37M
Capitalization4.96B
Lexeo Therapeutics
Price$5.07
Change-$0.12 (-2.31%)
Volume$274.73K
Capitalization167.7M
IONS vs LXEO Comparison Chart
Loading...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IONS vs. LXEO commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IONS is a Hold and LXEO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (IONS: $31.43 vs. LXEO: $5.07)
Brand notoriety: IONS and LXEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IONS: 88% vs. LXEO: 68%
Market capitalization -- IONS: $4.96B vs. LXEO: $167.7M
IONS [@Biotechnology] is valued at $4.96B. LXEO’s [@Biotechnology] market capitalization is $167.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IONS’s FA Score shows that 0 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • IONS’s FA Score: 0 green, 5 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, both IONS and LXEO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IONS’s TA Score shows that 2 TA indicator(s) are bullish while LXEO’s TA Score has 3 bullish TA indicator(s).

  • IONS’s TA Score: 2 bullish, 3 bearish.
  • LXEO’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than IONS.

Price Growth

IONS (@Biotechnology) experienced а -6.07% price change this week, while LXEO (@Biotechnology) price change was -20.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

IONS is expected to report earnings on Apr 30, 2025.

LXEO is expected to report earnings on Mar 17, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IONS($4.96B) has a higher market cap than LXEO($168M). IONS YTD gains are higher at: -10.097 vs. LXEO (-22.948). LXEO has higher annual earnings (EBITDA): -84.47M vs. IONS (-249.52M). IONS has more cash in the bank: 2.48B vs. LXEO (157M). LXEO has less debt than IONS: LXEO (10.4M) vs IONS (1.45B). IONS has higher revenues than LXEO: IONS (803M) vs LXEO (0).
IONSLXEOIONS / LXEO
Capitalization4.96B168M2,954%
EBITDA-249.52M-84.47M295%
Gain YTD-10.097-22.94844%
P/E RatioN/AN/A-
Revenue803M0-
Total Cash2.48B157M1,582%
Total Debt1.45B10.4M13,913%
FUNDAMENTALS RATINGS
IONS: Fundamental Ratings
IONS
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IONSLXEO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
66%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
Bearish Trend 11 days ago
72%
Bullish Trend 11 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
69%
Bullish Trend 11 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
70%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
61%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 20 days ago
70%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
72%
Bearish Trend 11 days ago
79%
View a ticker or compare two or three
Ad is loading...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTZCX52.670.46
+0.88%
FullerThaler Behvrll Uncnstd Eq C
GGUIX9.650.06
+0.63%
abrdn Focused U.S. Small Cap Eq Instl
FJACX11.390.04
+0.35%
Fidelity Series Small Cap Discovery
VGWIX21.680.04
+0.18%
Vanguard Global Wellesley Income Inv
PREJX27.05-0.03
-0.11%
Principal Real Estate Securities J

IONS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IONS has been loosely correlated with ALNY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IONS jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IONS
1D Price
Change %
IONS100%
-2.63%
ALNY - IONS
50%
Loosely correlated
-1.16%
AXON - IONS
43%
Loosely correlated
+1.37%
ARWR - IONS
41%
Loosely correlated
+2.84%
IDYA - IONS
36%
Loosely correlated
-2.38%
REGN - IONS
36%
Loosely correlated
-1.68%
More

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with RCKT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
-2.31%
RCKT - LXEO
36%
Loosely correlated
+0.98%
CABA - LXEO
35%
Loosely correlated
+12.76%
ARWR - LXEO
34%
Loosely correlated
+2.84%
PRME - LXEO
34%
Loosely correlated
+0.70%
IONS - LXEO
31%
Poorly correlated
-2.63%
More